Barry Sloane

CEO Barry Sloane buys 5,000 NEWT shares at $14.20; 4 of 5 prior same-ticker buys were well-timed at 90d, cluster pattern evident

Barry Sloane, President, Chairman & CEO, purchased 5,000 shares at $14.20 on 2026-06-15, bringing his holdings to 1,181,914 shares post-transaction. This open-market buy occurs within a cluster context: 2 other insiders bought within the past 14 days, suggesting coordinated management confidence. The timing signal is meaningful: at this same ticker (NEWT), Sloane's prior buy on 2026-01-14 declined 8.6% over 30 days and 9.7% over 90 days, but 4 of his 5 prior NEWT trades were well-timed at the 90-day mark, with the November 2025 buys each posting 30-day returns of +10.2% to +11.0% and 90-day returns of +31.4% to +32.4%. Current stock price is $14.30 (near the transaction price), up 12.8% over 30 days and 19.4% over 90 days, consistent with the strong momentum pattern Sloane captured in his November cluster. The company trades at a P/E of 6.38 with $38.2M quarterly revenue and $13.4M net income, presenting modest valuation metrics relative to market cap of $412.7M.

Barry Sloane (CEO) purchases 11,000 shares at $14.21 avg; stock up 12.8% in 30 days, 19.4% in 90 days

CEO Barry Sloane executed 3 separate purchases totaling 11,000 shares for $156,260.00 at a blended average price of $14.21, expanding his holdings to 1,176,914 shares. The stock has appreciated 12.8% over the prior 30 days and 19.4% over the prior 90 days, trading at $14.30 against a 52-week range of $9.59–$14.91. His same-ticker purchase history at NEWT shows 4 of 5 prior buys were followed by positive 90-day returns, with 3 consecutive purchases on 2025-11-03 each yielding 90-day gains between +31.4% and +32.4%, suggesting a pattern of well-timed entry points at this specific ticker. The company trades at a P/E of 6.38 on revenue of $38,166,000.00 and net income of $13,401,000.00 in the latest quarter.

CEO Sloane Barry buys 3,595 shares of NEWT at $13.91 as 3 other insiders also buy within 14 days; stock up 21.2% in 30 days, 39.7% in 90 days.

Sloane Barry, President, Chairman & CEO of NewtekOne, Inc., purchased 3,595 shares at $13.91 on 2026-01-14 for $50,006.45, increasing his holdings to 1,194,180 shares. This transaction occurs within a cluster pattern: 3 other insiders also bought within the past 14 days, suggesting coordinated confidence at the management level. The timing aligns with strong recent price momentum—NEWT has risen 21.2% over the past 30 days and 39.7% over 90 days, currently trading at $14.64 near its 52-week high of $14.64. Fundamentally, the company shows solid metrics with net income of $17,901,000.00 against revenue of $38,166,000.00 (latest quarter) and a P/E ratio of 7.14. Barry's cross-ticker buy track record demonstrates an 80.00% 90-day win rate with an average 90-day return of +8.7%, though his same-ticker history at NEWT (5 prior buys all on 2025-11-03) shows recent 30-day returns of +10.2% to +11.3%, with 90-day outcomes not yet measurable. The cluster buy pattern combined with strong momentum and management confidence warrants investor attention to whether this reflects conviction in upcoming catalysts or recognition of undervaluation relative to fundamentals.

NEWT: CEO Barry buys 10,000 shares at blended avg $10.22 on 2025-11-03; stock down 33.1% from 52-week high, P/E 5.09

Sloane Barry, Chairman & CEO, executed 5 separate purchases totaling 10,000 shares for $102,170.00 at an average price of $10.22 on 2025-11-03. The stock trades at $10.34 (current price), down 33.1% from its 52-week high of $15.46 and has declined 8.9% over the past 30 days and 9.1% over 90 days, indicating pronounced recent weakness. Barry's prior 5 trades at NEWT were all well-timed at the 90-day mark, with returns ranging from +3.7% to +20.6% over 90 days, establishing a pattern of accurate buy-timing at this specific ticker. The company's fundamentals remain intact with a P/E of 5.09, revenue of $38,166,000.00, and net income of $13,703,000.00 (latest quarter), suggesting the valuation compression is driven by price action rather than earnings deterioration. This purchase by the CEO amid a prolonged decline and following a consistent record of well-timed accumulation at this ticker warrants investor attention to whether the magnitude of recent price weakness has created an entry point the company's leader views as attractive.

NEWT CEO Sloane Barry purchased 2,000 shares at $10.39 on 2025-06-20; stock down 31.0% from 52-week high.

Sloane Barry, Chair & CEO of NewtekOne, filed 2 separate purchases totaling 2,000 shares for $20,784.80 at an average price of $10.39 on 2025-06-20. This represents a +0.2% increase to his 1.20M-share position. The stock currently trades at $10.67, down 31.0% from its 52-week high of $15.46 and off 14.2% over the last 90 days. Barry's cross-ticker track record shows 20 prior buys with a 90-day win rate of 33.33% and average 90-day return of -4.0%. At NEWT specifically, his prior buy on 2025-05-19 declined 7.1% over 30 days; four more recent May 29 buys remain too early to assess. The modest share increment and recent price deterioration warrant attention to whether the CEO purchase reflects fundamental conviction or routine portfolio activity in a stock trading near the low end of its 52-week range.

NEWT Chairman Sloane Barry purchases 10,000 shares for $108,610.70 at blended $10.86; part of cluster pattern with 2 other insiders buying in past 14 days

Sloane Barry executed 4 separate purchases totaling 10,000 shares for $108,610.70 on 2025-05-29, bringing his total holdings to 1,200,459 shares. This transaction occurs within a cluster: 2 other insiders also bought within the past 14 days, suggesting coordinated confidence at management level. Barry's cross-ticker track record shows 20 prior buys with a 71.43% 90-day win rate and average 90-day return of +3.0%, though outcomes at NEWT specifically remain unmeasurable due to recent timing of 5 prior NEWT trades on 2025-05-19. At current price of $11.12, the stock trades at P/E 5.79 with quarterly revenue of $38,166,000.00 and net income of $9,367,000.00, positioned at -28.1% from its 52-week high and a 30-day price change of +3.8%. The cluster buy pattern and relatively low valuation merit observation of whether management's recent accumulation reflects fundamental conviction.

NEWT CEO Sloane Barry buys 10,000 shares ($112.3K, $11.23 avg) in 5 transactions; stock near 27% markdown from 52-week high; 5 cluster buys within 14 days

NEWT Chairman & CEO Sloane Barry executed 5 separate purchases totaling 10,000 shares for $112,325.70 (blended average $11.23) on 2025-05-19, adding to his 1.19M-share post-transaction holdings. The timing coincides with the stock at -27.3% from its 52-week high of $15.46, despite a +9.9% 30-day rebound. This filing reflects a cluster pattern: 5 other insiders also bought within the past 14 days, suggesting coordinated board-level conviction about valuation at this price level. Across his full cross-ticker open-market history, Barry's 20 prior buys averaged a +10.7% 90-day return with an 83.33% win rate, though his prior 5 trades at NEWT (all buy orders on 2025-05-13) remain too recent to measure outcomes. At the P/E of 5.85 with net income of $9.4M on revenue of $38.2M, the stock trades at a material discount to historical levels, positioning this cluster acquisition as a potential test of whether the markdown reflects opportunity or deteriorating fundamentals.

Chairman SLOANE BARRY bought 10,000 shares at blended average $11.61 on 2025-05-13; stock now $11.19, down 27.6% from 52-week high.

Sloane Barry, Chairman & CEO, executed 8 separate purchases totaling 10,000 shares for $116,125.50 on 2025-05-13 at prices ranging from $11.56 to $11.68, establishing a blended average price of $11.61. This adds 0.9% to his existing 1.17M share holdings, bringing his post-transaction position to 1.18M shares. The timing is notable in context: NEWT stock currently trades at $11.19, down 27.6% from its 52-week high of $15.46, though it has risen 8.6% over the past 30 days and fallen 12.3% over 90 days. Barry's own prior trading record at NEWT shows mixed outcomes—3 buys executed in September 2024 demonstrated 90-day gains of +7.7% to +8.7%, but his two most recent NEWT purchases (November and December 2024) resulted in 90-day losses of -15.5% and -4.7%, respectively. Additionally, a cluster buy pattern emerged with 3 other insiders also acquiring shares within the prior 14 days, suggesting coordinated insider accumulation. Against his cross-ticker track record of 20 prior buys averaging +2.1% over 30 days and +4.9% over 90 days with a 60% win rate, this transaction represents continued open-market activity by leadership during a period of stock price pressure.

NEWT Chairman Sloane Barry bought 3,000 shares at $12.95; part of cluster pattern with 4 other insiders buying in past 14 days.

Sloane Barry, Chairman & CEO of NewtekOne, purchased 3,000 shares at $12.95 on 2024-12-23, adding to his post-transaction holdings of 1,164,855 shares. This transaction is noteworthy because it occurs within a broader cluster: 4 other insiders also bought within the past 14 days, indicating coordinated accumulation at the executive level. At the same-ticker level, Barry's prior 4 trades (all buys on 2024-09-23) showed 90-day returns ranging from +7.7% to +8.7%, with all 4 prior buys well-timed at the 90-day mark. The current stock price of $12.99 is down 16.0% from its 52-week high of $15.46 and down 10.6% over the past 30 days, though it has risen 7.3% over 90 days. At a P/E of 6.66 with net income of $11,934,000.00 and a market cap of $341,702,677.44, the company shows solid fundamentals relative to valuation metrics.

NEWT: Chairman Sloane Barry buys 3,000 shares at $14.75; now holds 1,161,855 shares (+0.3%)

Sloane Barry purchased 3,000 shares of NewtekOne at $14.75 on 2024-11-26, representing a modest 0.3% increment to his holdings of 1,161,855 shares. The current price of $14.37 is -7.0% from the 52-week high of $15.46, positioning the buy near recent lows within the annual range. His prior trades at NEWT (5 buys on 2024-09-23) showed strong 30-day returns of 11.0% to 13.3%, though 90-day outcomes are not yet measurable. At the company level, fundamentals remain solid with a P/E of 7.37 and net income of $11,934,000.00 on quarterly revenue of $38,166,000.00, suggesting the stock may be undervalued. The timing pattern at NEWT shows all prior purchases occurring at similar market conditions, but without a 90-day win rate, this buy carries typical insider-activity weight rather than a strong conviction signal.